Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

1452

Actual shortage: 202 (14%)
Anticipated shortage: 0 (0%)
Avoided shortage: 1 (0%)
Resolved: 1249 (86%)

Discontinuation Reports

231

To be discontinued: 3 (1%)
Discontinued: 228 (99%)
Reversed: 0 (0%)

Late reports

235 (14%)

Overdue reports

6 (3%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2019-09-19 2019-10-04 94375
ACT CLARITHROMYCIN XL 500MG TABLET (EXTENDED-RELEASE) Resolved 2020-01-09 2020-05-29 102945
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-03-06 2020-05-21 107986
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-03-12 2020-06-04 108607
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-08 110712
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-08 110716
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-09 110719
TEVA-MORPHINE SR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-04-23 110722
TEVA-MORPHINE SR 100MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-02 2020-05-08 110725
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-03 2020-05-08 110797
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-10 2020-05-29 111823
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-10 2020-06-04 111826
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-23 2020-05-08 113043
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-05-01 2020-05-08 113726
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2020-05-01 2020-05-21 113761
TEVA-MORPHINE SR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-18 2020-10-22 118247
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-25 2021-04-29 118960
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-09 2020-08-27 119889
ACT CLARITHROMYCIN XL 500MG TABLET (EXTENDED-RELEASE) Actual shortage 2020-07-09 2021-01-14 119901
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2020-07-16 2021-05-10 120473

Showing 1401 to 1420 of 1452

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64544
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64547
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64550
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64553
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623

Showing 1 to 20 of 231